Cargando…
Novel Potential Therapeutic Targets of PTPN Families for Lung Cancer
Despite the treatment of lung adenocarcinoma (LUAD) having partially improved in recent years, LUAD patients still have poor prognosis rates. Therefore, it is especially important to explore effective biomarkers and exploit novel therapeutic developments. High-throughput technologies are widely used...
Autores principales: | Wang, Chin-Chou, Shen, Wan-Jou, Anuraga, Gangga, Khoa Ta, Hoang Dang, Xuan, Do Thi Minh, Chen, Sih-Tong, Shen, Chiu-Fan, Jiang, Jia-Zhen, Sun, Zhengda, Wang, Chih-Yang, Wang, Wei-Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784538/ https://www.ncbi.nlm.nih.gov/pubmed/36556168 http://dx.doi.org/10.3390/jpm12121947 |
Ejemplares similares
-
Penetrating Exploration of Prognostic Correlations of the FKBP Gene Family with Lung Adenocarcinoma
por: Wang, Chin-Chou, et al.
Publicado: (2022) -
Circadian rhythm-related factors of PER and CRY family genes function as novel therapeutic targets and prognostic biomarkers in lung adenocarcinoma
por: Wang, Chin-Chou, et al.
Publicado: (2022) -
Glutamine synthetase regulates the immune microenvironment and cancer development through the inflammatory pathway
por: Xuan, Do Thi Minh, et al.
Publicado: (2023) -
Dysbindin Domain-Containing 1 in Prostate Cancer: New Insights into Bioinformatic Validation of Molecular and Immunological Features
por: Tram, Van Thi Ngoc, et al.
Publicado: (2023) -
Prognostic and Immune Infiltration Value of Proteasome Assembly Chaperone (PSMG) Family Genes in Lung Adenocarcinoma
por: Xuan, Do Thi Minh, et al.
Publicado: (2023)